Efficacy and safety of disitamab vedotin combination therapy in HER2-positive advanced gynecological cancers: A multicenter retrospective analysis.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Jing Liu, Lele Chang, Xinyu Zhang, Qin Xu
Institutions: Fujian Medical University, Fujian Provincial Cancer Hospital
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410812804